Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours
Mir, Olivier, Azaro, Analia, Merchan, Jaime, Chugh, Rashmi, Trent, Jonathan, Rodon, Jordi, Ohnmacht, Ute, Diener, J.T., Smith, Claire, Yuen, Eunice, Oakley, Gerard Joseph, Le Cesne, Axel, Soria, Jean-Charles, Benhadji, Karim A., Massard, Christophe
Published in European journal of cancer (1990) (01.11.2018)
Published in European journal of cancer (1990) (01.11.2018)
Get full text
Journal Article
Abstract CT048: Population pharmacokinetics and pharmacodynamics for an oral Notch inhibitor, LY3039478, in the first-in-man study
Yuen, Eunice, Patel, Bharvin, Smith, Claire, Posada, Maria, Bell, Robert, Ohnmacht, Ute, Massard, Christophe, Rodon, Jordi, Benhadji, Karim
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with Pemetrexed and cisplatin in patients with advanced cancer
Calvo, Emiliano, Chen, Victor J., Marshall, Mark, Ohnmacht, Ute, Hynes, Scott M., Kumm, Elizabeth, Diaz, H. Bruce, Barnard, Darlene, Merzoug, Farhana F., Huber, Lysiane, Kays, Lisa, Iversen, Philip, Calles, Antonio, Voss, Beatrice, Lin, Aimee Bence, Dickgreber, Nicolas, Wehler, Thomas, Sebastian, Martin
Published in Investigational new drugs (01.10.2014)
Published in Investigational new drugs (01.10.2014)
Get full text
Journal Article
First-in-human study of LY3039478, a Notch signaling inhibitor in advanced or metastatic cancer
Massard, Christophe, Azaro, Analia, Le Tourneau, Christophe, Soria, Jean-Charles, Alt, Marie, Smith, Claire, Ohnmacht, Ute, Oakeley, Gerard, Patel, Bharvin, Yuen, Eunice, Benhadji, Karim A., Rodon Ahnert, Jordi
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer
Azaro, Analia, Rodon, Jordi, Calles, Antonio, Braña, Irene, Hidalgo, Manuel, Lopez-Casas, Pedro P., Munoz, Manuel, Westwood, Paul, Miller, Joel, Moser, Brian A., Ohnmacht, Ute, Bumgardner, William, Benhadji, Karim A., Calvo, Emiliano
Published in Investigational new drugs (01.06.2015)
Published in Investigational new drugs (01.06.2015)
Get full text
Journal Article
Promoter methylation of RASSF1A, RARβ and DAPK predict poor prognosis of patients with malignant mesothelioma
Fischer, Jürgen R., Ohnmacht, Ute, Rieger, Norman, Zemaitis, Marius, Stoffregen, Clemens, Kostrzewa, Michael, Buchholz, Erika, Manegold, Christian, Lahm, Harald
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2006)
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2006)
Get full text
Journal Article
Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine
Fischer, Jürgen R, Ohnmacht, Ute, Rieger, Norman, Zemaitis, Marius, Stoffregen, Clemens, Manegold, Christian, Lahm, Harald
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2007)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2007)
Get full text
Journal Article
First-in-human phase I study of LY2780301, an oral P70S6K/AKT inhibitor, in patients with refractory solid tumors
Calvo, Emiliano, Benhadji, Karim Adnane, Azaro, Analia, Duran, Ignacio, Argiles, Guillem, Boni, Valentina, Ohnmacht, Ute, Wallin, Johan, Bumgardner, William Mark, Rodon Ahnert, Jordi
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Reduction of HLA-DR+ Lymphocytes after Treatment with Enzastaurin in Patients with Metastatic Thyroid Cancer
Smetak, Manfred, Weigang-Koehler, Karin, Hanauske, Axel, Ohnmacht, Ute, Lahn, Michael, Wilhelm, Martin, Birkmann, Josef
Published in Chemotherapy (Basel) (01.08.2008)
Published in Chemotherapy (Basel) (01.08.2008)
Get full text
Journal Article
Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumours
Hanauske, Axel-R, Endler, Corinna, Graefe, Tobias, Fleeth, Jochen, Scheel, Jobst von, Lüdtke, Frank E, Müller-Hagen, Sigrun, Depenbrock, Henrik, Ohnmacht, Ute, Bolling, Claus
Published in European journal of cancer (1990) (01.11.2008)
Published in European journal of cancer (1990) (01.11.2008)
Get full text
Journal Article
Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma
Fischer, Jürgen R, Ohnmacht, Ute, Rieger, Norman, Zemaitis, Marius, Stoffregen, Clemens, Kostrzewa, Michael, Buchholz, Erika, Manegold, Christian, Lahm, Harald
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2006)
Get full text
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2006)
Journal Article
Gemcitabine plus dose-escalated epirubicin in advanced breast cancer : results of a phase I study
LÜFTNER, D, FLATH, B, AKRIVAKIS, C, MERGENTHALER, H.-G, OHNMACHT, U, ARNING, M, POSSINGER, K
Published in Investigational new drugs (01.01.1998)
Published in Investigational new drugs (01.01.1998)
Get full text
Journal Article
VERFAHREN ZUR HERSTELLUNG VON POLYASPARTIMID
RAFLER,GERALD,DD, RUHNAU,INGRID,DD, JUNGHANSS,BAERBEL,DD, OHNMACHT,UTE,DD
Year of Publication 07.12.1988
Get full text
Year of Publication 07.12.1988
Patent